MannKind | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Adma Biologics USD 24K 0 2024-12
Dynavax Technologies USD 117.23M 117.11M 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Halozyme Therapeutics USD 117.62M 117.5M 2025-06
Insmed USD 211.11M 209.29M 2025-06
MacroGenics USD 628K 1000 2024-12
MannKind USD 306.33M 303.29M 2025-06
Merck USD 1.79B 0 2025-03
Novo Nordisk DKK 446M 0 2025-03
Pfizer USD 5.68B 5.2B 2025-06
Sanofi 1.22B 36.5M 2025-06
Xencor USD 71.3M 70.58M 2025-06


MannKind Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.